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The mountain slopes of the Himalayas, Alps,
Pyrenees, and Andes have been the world’s
most notorious foci of endemic goiter (1). The
northern frontiers of India extending from
Kashmir in the west to Assam in the east form
an extensive Himalayan goiter belt (2). Forty
million persons are believed to be exposed to
the risk ofgoiter in this belt and approximately
nine million are afflicted with it. The pio-
neering work of the late Sir Robert McCarrison
in the early part of this century focused
attention not only on the extent of the
Himalayan endemic goiter but also on its cause
and on the reaction of the thyroid to various
noxious influences, i.e., nutritional, toxic, and
infective (3).
Despite all that has been written about the
etiology and pathogenesis of endemic goiter,
many problems still remain unresolved. The
study by Stanbury and his co-workers (4), the
first of its kind, of the metabolism of iodine in
people with endemic goiter in western Argen-
tina, employing radioactive iodine and modern
chemical methods of assay of stable iodine,
indicated that lack of iodine in the diet was the
most probable cause in that area. Similar
observations confirming the primary role of
iodine deficiency have been made in other parts
of the world such as Venezuela, Holland,
Finland, Greece, Eastern and Western New
Guinea, and the Congo. Studies in Tasmania,
Scandinavia, Central Europe, and Colombia
suggest the operation of other goitrogenic
factors of dietary origin in the development of
the disease (5). It has been suggested that the
iodide deficiency hypothesis cannot explain
endemic goiter in every area and that other
factors may be significant. A naturally occur-
ring goitrogenic substance was isolated from
human foods (6). Clements (7) felt that
endemic goiter among the children in Tasmania
was probably due to ingestion of a goitrogenic
substance capable of interfering with the iodide
trapping mechanism. There are other scattered
observations that incriminate factors other thai
iodide deficiency (8-10), but to this date no
naturally occurring goitrogen has been shown
conclusively to be responsible for endemic
goiter in any community, although it may be
playing an adjunct role in some areas (1 1). Even
in Tasmania where there seemed to be a
definite possibility of a goitrogen playing a role,
recent studies indicate that iodine administra-
tion can effectively reduce goiter prevalence
there(ll, 12).
The etiological factors of Himalayan and
sub-Himalayan endemic goiter have been under
investigation for the past 16 years in our
laboratory and the results of some of these
studies have been reported (13-16). The
studies carried out so far in various areas in the
Himalayan goiter belt included field surveys of
prevalence, clinical evaluation, and biochemical
investigations. In recent years, our studies have
been extended to include Nepal (which is in the
Himalayan goiter belt), Ceylon, and further
studies were made in the Indian goiter belt
itself. This paper presents the results of these
more recent studies. The areas where studies of
endemic goiter have been made by our group in
India, Nepal, and Ceylon are indicated in Fig. 1.
The studies made in Ceylon have been pub-
lished (17), and are not discussed in detail here
again; only the results obtained are given in
relation to those obtained in the Himalayan
goiter belt in India and Nepal.
The results of studies made in goats living in
the endemic area and in rats under an experi-
mental iodine-deficient regimen in our labora-
tories are also presented in brief as they throw
considerable light on the findings obtained in
human studies.
Materials and methods
As indicated in Fig. I , the study was carried out in
several places located in the goiter belt but widely
separated from each other in each of the three
countries, India, Nepal, and Ceylon.
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FIG. 1. Map showing
studied.
India
Bihar. The study was made in the township of Betia
in the State of Bihar. A survey of several hundred
schoolchildren in Betia showed a goiter prevalence of
nearly 100%. The schoolchildren who had visible
goiter of varying grades were studied for ‘   I uptakes
and biochemical parameters. Some adult men and
women who were permanent residents of this area
were also investigated.
Uttar Pradesh. The study was carried out in
Padrauna, located in Deoria district of eastern Uttar
Pradesh (U.P.) A rapid clinical survey was conducted
in two schools, one college and neighboring villages. In
all, a total of 1 ,300 subjects were examined. The
prevalence of goiter in the school children and
inhabitants of surrounding villages was approximately
55%. Radioiodine and biochemical studies were
performed among schoolchildren and a representative
group of the adult population in this area.
Nepal
We surveyed two areas, one in Trishuli, situated
roughly in the central part of Nepal and the other in
Jumla, a valley situated in the high mountains of the
northwestern section. Schoolchildren in both areas
showed a goiter prevalence ranging between 74% and
100%. The villagers adjoining Trishuli had a frequency
ratio of approximately 65%, whereas the residents of
villages near Jumla showed a frequency of 87%. For
detailed clinical studies and measurement of thyroid
function, schoolchildren and adults of both sexes and
who were permanent residents of the area were
selected.
Studies in humans
Clinical assessments. To determine prevalence, the
classification proposal by the late Prof. Ryle (18) was
followed and clinical evaluation of thyroid status was
made by looking for the well-known signs of hypo-
and hyperthyroidism.
Radioiodine uptakes. Twenty-five to fifty micro-
curies of ‘  ‘ I was administered orally as a rule, and
neck uptakes were determined at the end of 24 hr.
Uptakes at earlier and later intervals were also
determined whenever feasible. The thyroid uptake of
1 3 1 I was measured with a Tracerlab Scintillation
Probe (P-20D) (Tracerlab, Richmond, California)
attached to a Tracerlab Rate Meter. The detector was
kept at a distance of 254 mm from the neck. In Nepal,
uptake measurements were performed using a scintilla-
tion probe especially designed for field studies by the
Bhabha Atomic Research Centre, Trombay, Bombay,
India.
Venous blood samples. These were collected in
iodine-free glass containers; serum or plasma was
separated and transported under ice to the laboratories
of the Institute in Delhi within a few days of
collection. Protein-bound iodine (PB’ ‘ I) in serum or
plasma was estimated by the modified method of
Barker and co-workers (19) and the results were
expressed as micrograms/100 ml.
For protein-bound radioactive iodine (PB ‘  ‘ I)
determinations, 48 hr after a tracer dose of radio-
iodine blood samples were collected and serum
separated. Proteins were precipitated in 1 or 2 ml of
serum with zinc sulfate and sodium hydroxide. The
precipitate was separated by centrifugation and ‘  ‘ I
activity in the precipitate measured in a well-type
scintillation counter (Tracerlab). The results were
expressed as percentage of dose administered per liter
of serum.
Plasma inorganic iodide (P11) was estimated by the
isotope dilution technique, using a tracer dose of ‘  ‘ I
(20) according to the formula:
P11 - chemical I in urine (micrograms/lOO ml) x
1 3 1 1 in plasma (percent of dose per milliliter)
“I in urine (percent of dose per milliliter)
Urinarv iodide. This was estimated on casual urine
samples, using the same method as for plasma PB ‘ 2 7 I.
Creatinine was estimated on the same samples by the
alkaline picrate method and the results were expressed
as micrograms of iodide per gram of creatinine.
To estimate the amount of iodide in drinking water,
we again employed the Barker et al. procedure (19).
The results were expressed as micrograms per liter.
T3 suppression test. Triiodothyronine suppressibil-
ity was studied using the method of Werner and
Spooner (21). Basal 24-hr ‘  ‘ I uptakes were deter-
mined initially. After 8 days of triiodothyronine
therapy at 120 ag/day per person, 24-hr ‘  ‘ I uptakes
were repeated on the 8th day of therapy.
TSH stimulation test. A tracer dose of ‘   I was
administered orally on the 1st day and ‘  ‘ I uptake
was measured 3 hr after the dose. Ten international
units of thyrotropin (Thytropar, Armour Pharmaceuti-
cal Co. , Kankakee, Illinois) were then administered
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Numbers in parentheses indicate number of samples analyzed.
a From (29).
intramuscularly. Twenty-four hours after the first
tracer dose, residual thyroidal radioactivity was mea-
sured, and then a second tracer dose of ‘  ‘ I was given
orally to the fasting patient. A 3-hr uptake was again
measured after correcting for residual activity from
the first tracer.
Perchlorate or thiocyanate discharge test. A tracer
dose of ‘  ‘ I was administered orally and 2-hr neck
uptakes were measured. At 2 hr, the subjects received
orally either 500 mg potassium perchiorate or 1 g
thiocyanate. One-hour and six-hour neck uptakes of
the radioactive iodine were recorded after administra-
tion of the drug.
lodoamino acid distribution in plasma. Plasma
iodoamino acids were separated by ascending paper
chromatography. The plasma samples, with the carrier,
were chromatographed on Whatman No. 3 paper using
butanol: ethanol: 2 N ammonia (5:1:2 v/v) solvent
system. The chromatograms were sprayed with pal-
ladium chloride to identify the inorganic iodide spot
and with ninhydrin in acetone to identify the
iodoamino acids. The spots corresponding to origin,
DIT, MIT, I, T4, and T3 were cut out and ‘‘I
activity was measured in a well-type scintillation
counter (Tracerlab). The results were expressed as
percentage of total radioactivity.
Studies i?l animals
Goat studies. Goats in the endemic area were given
75 to 100 iCi of ‘  ‘ I 48 hr prior to being killed after
which the thyroids were collected in ice and brought
to the laboratory in Delhi. Thyroid glands from Delhi
goats were collected in a similar manner. The ‘  ‘ I
incorporation in iodoproteins of these glands was
studied using polyacrylamide gel electrophoresis and
the incorporation in iodoamino acids was estimated by
paper electrophoresis. Details of the methodology
used is described elsewhere (16).
Rat studies. Forty albino rats, weighing between
130 and 160 g, were divided into four groups of 10
rats each. 1) Group A received a stock diet with an
adequate amount of iodine. 2) Group B was given a
low iodine diet obtained from Nutritional Biochemi-
cals Corporation, Cleveland, Ohio. 3) Group C was fed
a stock diet with an adequate amount of iodine and, in
addition, each rat received orally 150 mg potassium
perchlorate/day. 4) Group D received a stock diet with
TABLE 1
an adequate amount of iodine plus an oral dose of 5
mg propylthiouracil/day.
The animals were kept on the above diet schedule
for 45 days. After 45 days, each rat was injected with
S iCi of ‘  ‘ I intraperitoneally 24 hr before being
killed. Then the thyroid glands were removed and
t 3 I j incorporation in iodoproteins of these glands was
studied in the same manner as described for the goat
studies.
Results
The results obtained in the endemic areas of
the three countries are presented in Tables 1-3.
At the bottom of each table, corresponding
values obtained in a nonendemic area (Delhi)
and with identical methods of analysis being
used are presented for comparison. Results in
males and females are not shown, as they are
not significantly different from one another.
The data presented in the three tables deal
mainly with schoolchildren.
Table I shows the values of 24-hr neck
uptakes of ‘  ‘ I and urinary stable iodide
excretion. It is evident that in all the endemic
areas studied, 24-hr uptakes are markedly
elevated, whereas urinary iodide excretion is
low as compared with the values obtained in
the nonendemic area of Delhi. The mean
uptake at 24 hr in Jumla (Nepal) is higher than
that in other endemic areas studied, indicating a
high degree of endemicity. This is also borne
out by other indices. In Bihar, 2- and 6-hr ‘  ‘ I
neck uptakes were studied in 43 subjects. The
mean uptakes at both intervals were markedly
elevated; at 2 hr, the mean uptake was 55% and
at 6 hr it was 67%. The ‘  ‘ I uptakes in
Padrauna (eastern U.P.) were followed up to 96
hr in 10 cases. The uptakes remained markedly
high even at 96 hr in these subjects. The values
for iodide excretion per gram of creatinine were
Twenty-four-hour ‘  ‘ I neck uptake and un nary iodide excretion in end emic goiter of India, Nepal, and Ceylon
Country Place
Percent 24-hr neck
uptake of ‘  ‘ I
Urinary excretion of iodide, jig/g
creatinine
India
Nepal
Ceylon
Controls values#{176}
Uttar Pradesh
Bihar
Trishuli
Jumla
Horana
Delhi
68.7 ± 8.3 (70)
67.1 ± 12.3 (43)
71.1 ± 1.65 (41)
84.7 ± 1.88 (17)
77.6 (33)
42.4 ± 3.00 (15)
30.2 ± 2.87 (46)
21.6 ± 1.59 (40)
20.2 ± 3.04(11)
20.15 ± 3.00 (6)
76.4 ± 10.2 (10)
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TABLE 2
Serum protein-bound iodine, protein-bound radioiodine, and plasma inorganic iodide values in endemic goiter
areas
Country Place PB’ 2 7 I, pg/100 ml PB’  ‘ I, % dose/liter P11, s.og/lOO ml
India Uttar Pradesh
Bihar
3.87 ± 0.31 (24)
3.00 ± 1.43 (13)
0.53 ± 0.130 (11) 0.096 ± 0.021 (12)
Nepal Trishuli
Jumla
4.10 ± 0.26 (15)
4.43 ± 0.44 (12)
1.87 ± 0.625 (12)
1.53 ± 0.504 (12)
0.088 ± 0.017 (8)
Ceylon Horana 5.60 ± 0.31 (18) 1.09 ± 0.14 (13) 0.089 ± 0.013 (14)
Control Delhia 6.00±0.70(15) 0.115±0.02 (15) 0.137±0.018(10)
values
Numbers in parentheses indicate number of samples analyzed.
#{176}From(29).
TABLE 3
Mean iodine content of water samples
in endemic goiter.
Country Place
Iodine content of
water, pg/liter
India UttarPradesh
Bihar
0.298 (11)
0.205 (8)
Nepal Trishuli
Jumla
0.1 25 (5)
0.107 (4)
Ceylon Horana 1.25 (4)
Control Delhi 9.00 (3)
values
Numbers in parentheses indicate the number of
samples analyzed.
comparable in all the areas of endemic goiter
studied and were less than 40 j.zg, the lower
limit of normal as suggested by Follis and
co-workers (22).
Table 2 gives the data on protein-bound
iodine, protein-bound radioactive iodine, and
plasma inorganic iodide. The values for PB’ 2 1
from endemic goiter areas in India and Nepal
were either below normal or near the lower
limit of normal. The PB’ 2 7 I values obtained
from Ceylon were, however, comparable to the
values obtained from the nonendemic area of
(Delhi). Endemic goiter in Ceylon is not as
severe as in India and Nepal as is borne out by
the prevalence rates of goiter. The PB’  ‘ I
values in plasma 48 hr after administration of a
tracer dose of ‘  ‘ I in all the areas studied were
extremely high. This indicates the rapidity with
which the thyroid hormones are synthesized
and released into the circulation. Obviously, the
iodide pool in the thyroid is markedly dimin-
ished. A significant reduction in plasma inor-
ganic iodide concentration is evident in all the
endemic areas as compared with the values
obtained from the nonendemic area.
Table 3 shows the iodine content of water
from endemic areas in the three countries.
Iodine content of water in Jumla (Nepal) was
the lowest of all the endemic areas studied.
Indeed, the endemicity of Jumla represents one
of the most severe we have encountered. It was
at Jumla that a striking number of deaf mutes,
cretins, and persons with various other disturb-
ances of mental and physical development were
encountered.
Triiodothyronine suppression was carried out
in 12 subjects, 6 in Padrauna (eastern U.P.) and
6 in Nepal. Of the six subjects studied in U.P.,
five showed suppression of 45 to 50% of the
basal value, whereas one showed 38% suppres-
sion. In Nepal, of six subjects, two showed
suppression of uptakes up to 46 to 48% of the
basal value; in three others, the suppression was
approximately 29 to 38%, and one showed no
response.
A TSH stimulation test was done in four
subjects in U.P. and two in Nepal. None of the
persons studied showed any stimulation after
administration of TSH, indicating that their
thyroids were already being stimulated
maximally.
The perchlorate or thiocyanate discharge test
was carried out in eight subjects from eastern
U.P. and six in Bihar. None showed any
discharge after receiving the drug.
Table 4 shows iodoamino acid distribution in
plasma 48 hr after a tracer dose of radioiodine
was administered in eight subjects. These
samples were collected during the studies
carried out in Nepal. It is evident that in all
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a Expressed as percent of total radioactivity.
except one, the proportion of radioactivity
found in triiodothyronine is equal to or greater
than that of thyroxine. In normal persons, the
proportion of radioactivity in triiodothyronine
is approximately 5% of the total radioactivity
in iodothyronine (23). There would seem to be
TABLE 4
lodoamino acid distribution in plasma’
Subject no. Original DIT MIT I T4 T,
14 19.0 3.6 11.1 1.6 25.0 40.1
21 3.4 10.1 5.0 16.9 28.8 35.5
65 0.0 4.5 7.2 1 1.8 35.5 40.9
66 0.0 2.1 18.2 13.9 30.1 35.5
74 12.0 0.0 28.0 48.0 12.0
84 5.0 8.9 18.8 31.1 35.5
85 18.8 15.3 8.2 28.2 29.3
86 6.9 21.4 18.8 25.5 28.3
a Expressed as percent of total radioactivity.
TABLE 5
a preferential secretion of triiodothyronine in
endemic goiter.
Animal studies
Goats. Table 5 shows the distribution of
iodoamino acids in the thyroid glands of
goats living in endemic and control areas.
Thyroids of goats from the endemic area have
higher MIT/DIT and T3/T4 ratios than those
from the control area.
Table 6 shows the ‘   I incorporation in
iodoproteins of thyroid glands of goats from
endemic and control areas. The results show
that there is more incorporation in 27S
iodoproteins in the glands from the endemic
area than in those from Delhi. Consequently,
incorporation of ‘  ‘ I in l9S iodoprotein in
glands of goats living in endemic areas is less
than those living in Dethi.
Distribution of iodoamino acids in the goat thyroid glands from endemic and control areas”
Area Original DIT MIT I T4 T,
Endemic (10) 0.7 ± 0.16 35.9 ± 1.71 39.1 ± 2.42 16.3 ± 2.42 2.4 ± 0.43 6.2 ± 0.75
Control (10) 3.3 ± 0.35 53.8 ± 1.26 30.8 ± 0.89 6.4 ± 0.98 4.3 ± 0.47 0.9 ± 0.10
Numbers in parentheses indicate the number of goat glands analyzed.
a Expressed as percent of total radioactivity.
TABLE 6
Gel electrophoretic pattern of goat thyroid proteins from endemic and control areas”
Area 33S 27S 195 125 85 35
Endemic (7) 6.4 ± 1.87 24.7 ± 4.34 65.8 ± 3.41 1.1 ± 0.39 1.2 ± 0.24 0.9 ± 0.29
Control (9) 5.5 ± 0.33 10.9 ± 0.33 80.3 ± 0.75 1.5 ± 0.27 1.0 ± 0.23 1.0 ± 0.17
Numbers in parentheses indicate the number of goat glands analyzed.
a Expressed as percent of total radioactivity.
TABLE 7
Gel electrophoretic pattern of rat thyroid proteins in different experimental groups”
Group
No. of
animals 335 275 195 12S 85 3S
Total I
contents
ofgland,pg
Total weight
of gland,mg
Stock diet
Low iodine
diet
KCIO4 treated
PTU treated
10
10
10
10
2.10
± 0.24
4.58
± 0.46
5.00
± 0.34
2.47
± 0.28
10.04
± 0.65
26.35
± 0.50
30.00
± 0.85
19.35
± 0.62
83.00
± 0.86
66.06
± 0.87
61.40
± 0.74
74.20
± 1.03
2.70
± 0.42
1 .45
± 0.36
2.15
± 0.23
2.1 1
± 0.32
1.22
± 0.18
0.60
± 0.1 1
1.21
± 0.25
1.1 1
± 0.19
0.72
± 0.13
0.5 1
± 0.09
0.61
± 0.10
0.68
± 0.14
93.00
± 3.78
24.0
± 1.60
15.5
± 0.88
25.0
± 2.71
28.0
± 1.96
54.5
± 4.37
67.5
± 3.1 1
66.00
± 2.33
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Rats. Table 7 shows ‘  ‘ I incorporation in
iodoproteins of rat thyroid glands in different
experimental groups. The incorporation in 275
iodoprotein was highest in the group receiving
potassium perchlorate followed by the low
iodine group, then the PTU treated group and
then lastly, the stock diet groups. There was
consequential reduction in ‘  ‘ I incorporation
in I 95 iodoprotein in these groups. The ‘  ‘ I
incorporation in 275 iodoprotein seems to be
inversely related to the amount of iodine
present in the gland.
Thyroid histology
Human thyroids obtained at autopsy from
the Indian goiter belt and from nonendemic
areas in India have been studied (15). Even at
birth the gland is enlarged two to three times
normal in the goiter zone and shows intense
hyperplasia. The hyperplasia and hypertrophy
of the thyroid continues to be persistent at all
ages with little or no involution and colloid
accumulation . Nodular transformation takes
place at multiple sites throughout the gland at a
relatively young age in the people of the
Himalayas and progresses with age.
Discussion
Studies of iodine metabolism in the Hima-
layan goiter zones of India and Nepal showed:
a) markedly increased avidity of the thyroid to
radioiodine, b) reduced excretion of stable
iodine in urine, c) extremely low levels of
iodine in the drinking water, d) normal or
reduced protein-bound iodine in plasma, and e)
low inorganic iodide concentration in plasma.
These findings are compatible with the hy-
pothesis that environmental deficiency of io-
dine is the primary factor responsible for
endemic goiter in these areas. In Ceylon, the
protein-bound iodine in plasma was normal and
the iodine content of drinking water was not as
low as observed in other areas. This may be
because the endemicity is not as severe in
Ceylon as compared with the Himalayas. Goiter
prevalence rates confirm this.
Perchlorate or thiocyanate discharge tests
provided no evidence of a peroxidase defect. It
appears unlikely that genetic isolation and
consequent inherited defects in the synthesis of
thyroid hormones play a major part in the
etiology. The responses are not indicative of
goitrogens. The data suggest that iodine defi-
ciency is more severe in Nepal and India than in
Ceylon.
The thyroid makes an interesting adaptation
to maintain internal homeostasis in the face of
severe iodine deficiency. The increase in uptake
and clearance of    I and the rapid turnover of
labeled iodine within the gland are reflections
of attempted functional compensation. The
preferential synthesis and secretion of triio-
dothyronine is another compensatory mechan-
ism, for in its manufacture, an atom of iodine is
conserved for each molecule of hormone, and,
in the process, a much more potent hormone is
formed. Triiodothyronine suppresses the activ-
ity of the gland in most subjects studied,
indicating that the gland is under TSH stimula-
tion. Recently, in another area in eastern U.P.,
studies were carried out by us to measure the
levels of circulating TSH and the reserves of
TSH in endemic goiter by stimulating the
pituitary with TRH (24). These studies indicate
that TSH levels are high in endemic goiter as are
also the reserves of TSH. It is possible that the
levels of TRH are also increased in this condi-
tion. The fact that TSH administration could
not further stimulate the already stimulated
thyroid is an indication that the gland is already
subjected to maximal stimulation. Despite all
this elaborate adaptation to iodine deficiency,
in severely endemic areas like Nepal, there is
evidence that in some persons this mechanism
has failed to maintain internal homeostasis, as
reflected in low PB’ 2 7  in plasma and in the
emergence of symptoms of hypothyroidism. If
the hypothesis that endemic deaf mutism and
cretinism commonly seen in the Himalayan
endemic region are manifestations of earlier
intrauterine damage as a result of iodine
deficiency or hypothyroidism, or both, is ac-
cepted, then the adaptive failure assumes even
greater proportions in this population.
We conducted a study ofgoats to investigate
further the mechanism of adaptation of thyroid
gland to iodine deficiency. Earlier work from
this laboratory (15) revealed that goat thyroid
glands from endemic areas show pathophysio-
logical changes similar to those found in the
gl ands of humans living in the same area. Goats
raised in Dethi, an area that has abundant
iodine and that is free from endemic goiter,
served as controls. The results showed that the
thyroids from the endemic area had higher
MIT/DIT and T3/T4 ratios than those from the
control area. Presumably, more T3 was being
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synthesized in endemic glands than T4 . As
mentioned earlier, we had observed more T3 in
the circulation of subjects with endemic goiter.
A similar finding was reported by Ibbertson et
al. (25) in the goitrous population from
northeastern Nepal.
The mechanism of thyroid hormone syn-
thesis was investigated in detail by Taurog and
Howells (26). They showed that the tertiary
structure of thyroglobulin is important in the
coupling reaction of iodotyrosines to form
thyroid hormones. The coupling reaction is
intramolecular and perhaps is not enzyme
mediated (27). Thus, the tertiary structure of
thyroglobulin is such that the DIT residues are
situated in a favorable position at the coupling
site. As there are more MIT residues than DIT
in iodine-deficient glands, it is probable that at
the coupling site in the thyroglobulin molecule,
instead of two DIT residues there may be one
MIT and one DIT residue in these glands. This
would result in the production of more T3 than
T4 , which, in endemic goiter then may be
viewed as a direct consequence of iodine
deficiency rather than as an adaptive mecha-
nism.
The incorporation of ‘  ‘ I in iodoproteins
showed that there is more incorporation in 275
iodoproteins in the glands of those living in an
endemic area than in those from the Dethi area.
Consequently, incorporation of ‘  ‘ I in 195 in
the former is relatively less than that in the
latter. The 275 iodoprotein has the same
subunits as that of 195 (thyroglobulin) and has
a high iodine content compared with 19S
(thyroglobulin). 275 lodoprotein accounts for a
significant fraction of iodine stores in the
thyroid gland (28). In the thyroid of goats
residing in endemic areas, the synthesis of more
275 iodoprotein, which is more iodinated and
can produce more hormone mole per mole than
195, may be considered as an adaptive mecha-
nism of the gland to iodine deficiency. It is
logical to consider that just as 19S iodoprotein
in iodine deficiency can produce more T3 than
T4 , 275 iodoprotein may also do so under
similar conditions, provided that the mecha-
nism of coupling reaction in both iodoproteins
is similar.
In order to explore which factors, such as
iodine concentration in the gland or TSH
influence, are responsible for differential aggre-
gation of subunits to form more 275 iodopro-
tein in iodine-deficient glands, experiments
using rats were conducted. The results indicate
that the iodine concentration in the gland per
se has more influence on the differential
aggregation of the subunits to form either 275
or 195 than TSH.
The thyroid makes an adaptation to maintain
internal homeostasis in iodine deficiency.
Severe iodine deficiency produces low PBI
values with increased circulating TSH levels.
There is a possibility of more TRH influence in
such a situation. Thus, the control seems to be
both at the hypothalamus-pituitary axis and the
pituitary-thyroid axis. Within the gland, due to
low iodine concentration, there is presumably
preferential formation of 27S iodoprotein,
which is more efficient in producing thyroid
hormones than 195 (thyroglobulin). The inter-
relationship between all these events is the
present fascination in the study of endemic
goiter.
Summary
Goiter prevalence and iodine metabolism
were studied in areas of endemic goiter in the
Himalayas in India and Nepal. Similar studies
were also made in Ceylon. The results are
compatible with the hypothesis that severe
environmental deficiency of iodide is the
primary factor responsible for endemic goiter in
these areas. The endemicity was less severe in
Ceylon than in India and Nepal. The thyroid
glands of persons living in endemic areas show
an interesting adaptive response to maintain
internal homeostasis in the face ofsevere iodine
deficiency.
The mechanism of this adaptation was
studied in thyroids of goats raised in endemic
and nonendemic areas. Thyroids of goats living
in an area of severe iodine deficiency showed
higher MIT/DIT and T3 /T4 ratios than glands
of those in an area of iodine abundance. There
was a higher incorporation of ‘   I in 27S
iodoproteins in the iodide-deficient glands. A
decrease in iodine concentration of the thyroid
and an increase in circulating TSH levels are
possibly involved in mediating this response but
of the two, the former mechanism seems more
likely than the latter. a
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